Kenvue Stock vs Competition: Who Wins?
With Kenvue surging 17% in a Week, it makes sense to re-evaluate vs its peers. Consistently assessing alternatives is core to a sound investment approach. Here is how Kenvue (KVUE) stock stacks up against its peers in size, valuation, growth and margin.
- KVUE’s operating margin of 17.6% is strong, higher than most peers though lower than PG (24.1%).
- KVUE’s revenue growth of -2.9% in the last 12 months is negative, lagging PG, ELF but outpacing EL, COTY.
- KVUE’s stock is down 23.8% in last 1 year, and trades at a PE of 22.6; it underperformed PG, EL.
As a quick background, Kenvue is the world’s largest pure-play consumer health company by revenue, combining science, human insights, and digital capabilities to empower 1.2 billion people to live healthier lives daily.
A single stock can be risky, but there is a huge value to a broader, diversified approach. Should you buy one stock you like or build a portfolio designed to win across cycles? Our numbers show that the Trefis High Quality Portfolio has turned stock-picking uncertainty into market-beating consistency. This portfolio is incorporated in the asset allocation strategy of Empirical Asset Management — a Boston area wealth manager and Trefis partner — whose asset allocation framework yielded positive returns during the 2008-09 period when the S&P lost more than 40%.
| KVUE | PG | EL | ELF | COTY | |
|---|---|---|---|---|---|
| Market Cap ($ Bil) | 32.4 | 344.2 | 31.7 | 4.2 | 3.3 |
| Revenue ($ Bil) | 15.0 | 84.9 | 14.3 | 1.3 | 5.8 |
| PE Ratio | 22.6 | 20.5 | -27.9 | 42.5 | -8.5 |
| LTM Revenue Growth | -2.9% | 1.2% | -8.2% | 18.6% | -5.7% |
| LTM Operating Margin | 17.6% | 24.1% | 8.0% | 11.6% | 8.2% |
| LTM FCF Margin | 10.9% | 17.6% | 4.7% | 10.1% | 5.2% |
| 12M Market Return | -23.8% | -7.7% | 34.8% | -36.5% | -48.3% |
Why does this matter? KVUE just went up 17.5% in a week – peer comparison puts stock performance, valuation, and financials in context – highlighting whether it is truly outperforming, lagging behind, and above all – can this continue?
Revenue Growth Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| KVUE | -2.9% | – | 0.1% | 3.3% | -0.7% |
| PG | 1.2% | 0.3% | 2.5% | 2.3% | |
| EL | -8.2% | -8.2% | -1.9% | -10.3% | |
| ELF | 18.6% | 28.3% | 76.9% | 47.6% | |
| COTY | -5.7% | -3.7% | 10.2% | 4.7% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| KVUE | 17.6% | – | 17.0% | 16.1% | 18.0% |
| PG | 24.1% | 24.3% | 23.7% | 22.1% | |
| EL | 8.0% | 8.0% | 10.0% | 11.1% | |
| ELF | 11.6% | 12.0% | 14.6% | 11.8% | |
| COTY | 8.2% | 9.0% | 9.5% | 9.7% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| KVUE | 22.6 | – | 39.7 | 23.9 | � |
| PG | 20.5 | 24.7 | 23.2 | 24.5 | |
| EL | -27.9 | -23.8 | 134.6 | 88.3 | |
| ELF | 42.5 | 63.0 | 61.9 | 47.2 | |
| COTY | -8.5 | -16.5 | 121.5 | 14.3 |
While peer comparison is critical, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.